Лечение COVID-19 при беременности и кормлении грудью

Анатомо-физиологические особенности беременных женщин делают их особенно восприимчивыми к осложнениям коронавирусного заболевания (COVID-19). Повышенная свертываемость крови с риском тромбоэмболических осложнений характерна в период беременности, она еще более усиливается, когда ассоциирована с протромбо-тическими состояниями, такими как COVID-19. Лечение COVID-19 является предметом дискуссии даже для небеременных. Во время беременности медикаментозная терапия ограничена из-за тератогенности некоторых препаратов и анатомо-физиологических особенностей, особенно в поздние сроки беременности у пациенток с дыхательной недостаточностью. Поэтому основное внимание в лечении беременных женщин должно уделяться изоляции, мониторингу жизненно важных показателей плода и матери, сократительной активности матки. Назначение препаратов и общие принципы ведения должны основываться на гестационном возрасте и клиническом состоянии матери. Выбор способа родоразрешения определяется акушерскими показаниями и тяжестью течения COVID-19. Следует сохранять грудное вскармливание при условии использования масок и средств для гигиены рук. Лечение беременных женщин с COVID-19 имеет важные особенности, которые необходимо учитывать для принятия лучшего решения с целью сохранения здоровья матери и плода.

1. Wenling Y., Junchao Q., Xiao Z., Ouyang S. Pregnancy and COVID-19: management and challenges. Rev Inst Med Trop Sao Paulo. 2020; 62: e62. https://doi.org/10.1590/s1678-9946202062062. PMID: 32876296.

2. Di Renzo G.C., Giardina I. Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis. Am J Obstet Gynecol. 2020 Jul; 223(1): 135. https://doi.org/10.1016/j.ajog.2020.04.017. PMID: 32333857.

3. Boushra M.N., Koyfman A., Long B. COVID-19 in pregnancy and the puerperium: A review for emergency physicians. Am J Emerg Med. 2021 Feb; 40: 193-198. https://doi.org/10.1016/j.ajem.2020.10.055. PMID: 33162266.

4. Fesler M.C., Stricker R.B. Pre-Exposure prophylaxis for COVID-19 in pregnant women. Int J Gen Med. 2021 Jan 26; 14: 279-284. https://doi.org/10.2147/IJGM.S295627. PMID: 33542646.

5. Wastnedge E.A.N., Reynolds R.M., van Boeckel S.R., et al. Pregnancy and COVID-19. Physiol Rev. 2021 Jan 1; 101(1): 303-318. https://doi.org/10.1152/physrev.00024.2020. PMID: 32969772.

6. Castro P., Matos A.P., Werner H., et al. Covid-19 and pregnancy: An Overview. Rev Bras Ginecol Obstet. 2020 Jul; 42(7): 420426. English. https://doi.org/10.1055/s-0040-1713408. PMID: 32559801.

7. Lin L., Lu L., Cao W., Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec; 9(1): 727-732. https://doi.org/10.1080/22221751.2020.1746199. PMID: 32196410.

8. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020 Apr 7; 323(13): 1239-1242. https://doi.org/10.1001/jama.2020.2648. PMID: 32091533.

9. Breslin N., Baptiste C., Gyamfi-Bannerman C., et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020 May; 2(2): 100118. https://doi.org/10.1016/j.ajogmf.2020.100118. PMID: 32292903.

10. Berry M., Wang A., Clark S.M., et al. Clinical stratification of pregnant COVID-19 patients based on severity: A single academic center experience. Am J Perinatol. 2021 Apr; 38(5): 515522. https://doi.org/10.1055/s-0041-1723761. PMID: 33548937.

11. Rasmussen S.A., Smulian J.C., Lednicky J.A., et al. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020 May; 222(5): 415-426. https://doi.org/10.1016/j.ajog.2020.02.017. PMID: 32105680.

12. Lopez M., Gonce A., Meler E., et al. Coronavirus disease 2019 in pregnancy: A clinical management protocol and considerations for practice. Fetal Diagn Ther. 2020; 47(7): 519-528. https://doi.org/10.1159/000508487. PMID: 32535599.

13. McCullough P.A., Alexander P.E., Armstrong R., et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med. 2020 Dec 30; 21(4): 517-530. https://doi.org/10.31083/j.rcm.2020.04.264. PMID: 33387997.

14. Berlivet L., Lowy I. Hydroxychloroquine controversies: Clinical trials, epistemology, and the democratization of science. Med Anthropol Q. 2020 Dec; 34(4): 525-541. https://doi.org/10.1111/maq.12622. PMID: 33210338.

15. Shah S., Majmudar K., Stein A., et al. Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization. Acad Emerg Med. 2020 Aug; 27(8): 681-692. https://doi.org/10.1111/acem.14053. PMID: 32779828.

16. Roberts C.M., Levi M., McKee M., et al. COVID-19: a complex multisystem disorder. Br J Anaesth. 2020 Sep; 125(3): 238-242. https://doi.org/10.1016/j.bja.2020.06.013. PMID: 32731958.

17. Echeverria-Esnal D., Martin-Ontiyuelo C., Navarrete-Rouco M.E., et al. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2021 Feb; 19(2): 147-163. https://doi.org/10.1080/14787210.2020.1813024. PMID: 32853038.

18. Wang M., Cao R., Zhang L., et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar; 30(3): 269-271. https://doi.org/10.1038/s41422-020-0282-0. PMID: 32020029.

19. Satarker S., Ahuja T., Banerjee M., et al. Hydroxychloroquine in COVID-19: Potential mechanism of action against SARS-CoV-2. Curr Pharmacol Rep. 2020 Aug 24: 1-9. https:// doi.org/10.1007/s40495-020-00231-8. PMID: 32864299.

20. Tripathy S., Dassarma B., Roy S., et al. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Int J Antimicrob Agents. 2020 Aug; 56(2): 106028. https://doi.org/10.1016/j.ijantimicag.2020.106028. PMID: 32450198.

21. Kashour Z., Riaz M., Garbati M.A., et al. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2021 Jan 1; 76(1): 30-42. https://doi.org/10.1093/jac/dkaa403. PMID: 33031488.

22. Risch H.A. Early outpatient treatment of symptomatic, high-risk COVID-19 patients that should be ramped up immediately as key to the pandemic crisis. Am J Epidemiol. 2020 Nov 2; 189(11): 12181226. https://doi.org/10.1093/aje/kwaa093. PMID: 32458969.

23. Zhou D., Dai S.M., Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 Jul 1; 75(7): 16671670. https://doi.org/10.1093/jac/dkaa114. PMID: 32196083.

24. Lacroix I., Benevent J., Damase-Michel C. Chloroquine and hydroxychloroquine during pregnancy: What do we know? Therapie. 2020 Jul-Aug; 75(4): 384-385. https://doi.org/10.1016/j.therap.2020.05.004. PMID: 32418732.

25. Ahmed S., Karim M.M., Ross A.G., et al. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis. 2021 Feb; 103: 214-216. https://doi.org/10.1016/j.ijid.2020.11.191. PMID: 33278625.

26. Kaur H., Shekhar N., Sharma S., et al. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep. 2021 Jan 3: 1-14. https://doi.org/10.1007/s43440-020-00195-y. PMID: 33389725.

27. Nicolas P., Maia M.F., Bassat Q., et al. Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health. 2020 Jan; 8(1): e92-e100. https://doi.org/10.1016/S2214-109X(19)30453-X. PMID: 31839144.

28. Mahmoud D.B., Shitu Z., Mostafa A. Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19? J Genet Eng Biotechnol. 2020 Jul 28; 18(1): 35. https://doi.org/10.1186/s43141-020-00055-5. PMID: 32725286.

29. Domjahn B.T., Hlavsa M.C., Anderson B., et al. A survey of U.S. obstetrician-gynecologists' clinical and epidemiological knowledge of cryptosporidiosis in pregnancy. Zoonoses Public Health. 2014 Aug; 61(5): 356-363. https://doi.org/10.1111/zph.12078. PMID: 24119338.

30. Bleyzac N., Goutelle S., Bourguignon L., Tod M. Azithromycin for COVID-19: more than just an antimicrobial? Clin Drug Investig. 2020 Aug; 40(8): 683-686. https://doi.org/10.1007/s40261-020-00933-3. PMID: 32533455.

31. Million M., Lagier J.C., Gautret P., et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May-Jun; 35: 101738. https://doi.org/10.1016/j.tmaid.2020.101738. PMID: 32387409.

32. Sisti G., Schiattarella A., Sisti A. Treatment of COVID-19 in pregnancy with hydroxychloroquine and azithromycin: a case report. Acta Biomed. 2020 Jul 16; 91(4): e2020123. https://doi.org/10.23750/abm.v91i4.10216. PMID: 33525254.

33. Sarkar M., Woodland C., Koren G., Einarson A.R. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth. 2006 May 30; 6: 18. https://doi.org/10.1186/1471-2393-6-18. PMID: 16734900.

34. Andersson N.W., Olsen R.H., Andersen J.T. Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study. BMJ. 2021 Feb 10; 372: n107. https://doi.org/10.1136/bmj.n107. PMID: 33568349.

35. Goldstein L.H., Berlin M., Tsur L., et al. The safety of macrolides during lactation. Breastfeed Med. 2009 Dec; 4(4): 197-200. https://doi.org/10.1089/bfm.2008.0135. PMID: 19366316.

36. Cross R., Ling C., Day N.P., et al. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf. 2016; 15(3): 367-382. https://doi.org/10.1517/14740338.2016.1133584. PMID: 26680308.

37. Wormser G.P., Wormser R.P., Strle F., et al. How safe is doxycycline for young children or for pregnant or breastfeeding women? Diagn Microbiol Infect Dis. 2019 Mar; 93(3): 238-242. https://doi.org/10.1016/j.diagmicrobio.2018.09.015. PMID: 30442509.

38. Skalny A.V., Rink L., Ajsuvakova O.P., et al. Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med. 2020 Jul; 46(1): 17-26. https://doi.org/10.3892/ijmm.2020.4575. PMID: 32319538.

39. Zahiri Sorouri Z., Sadeghi H., Pourmarzi D. The effect of zinc supplementation on pregnancy outcome: a randomized controlled trial. J Matern Fetal Neonatal Med. 2016; 29(13): 2194-2198. https://doi.org/10.3109/14767058.2015.1079615. PMID: 26365330.

40. Pereira M., Dantas Damascena A., Galvao Azevedo L.M., et al. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020 Nov 4: 1-9. https://doi.org/10.1080/10408398.2020.1841090. PMID: 33146028.

41. Palacios C., Kostiuk L.K., Pena-Rosas J.P Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019 Jul 26; 7(7): CD008873. https://doi.org/10.1002/14651858.CD008873.pub4. PMID: 31348529.

42. Nørrisgaard P.E., Haubek D., Kuhnisch J., et al. Association of high-dose vitamin D supplementation during pregnancy with the risk of enamel defects in offspring: A 6-year follow-up of a randomized clinical trial. JAMA Pediatr. 2019 Oct 1; 173(10): 924-930. https://doi.org/10.1001/jamapediatrics.2019.2545. PMID: 31381020.

43. Hemilä H., Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013 Jan 31; 2013(1): CD000980. https://doi.org/10.1002/14651858. CD000980.pub4. PMID: 23440782.

44. Boretti A., Banik B.K. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome. PharmaNutrition. 2020 Jun; 12: 100190. https://doi.org/10.1016/j.phanu.2020.100190. PMID: 32322486.

45. McIntosh J.J. Corticosteroid guidance for pregnancy during COVID-19 pandemic. Am J Perinatol. 2020 Jun; 37(8): 809-812. https://doi.org/10.1055/s-0040-1709684. PMID: 32274772.

46. Lopez Zuniga M.A., Moreno-Moral A., Ocana-Granados A., et al. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response. PLoS One. 2021 Jan 28; 16(1): e0243964. https://doi.org/10.1371/journal.pone.0243964. PMID: 33507958.

47. Szente Fonseca S.N., de Queiroz Sousa A., Wolkoff A.G., et al. Risk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis. Travel Med Infect Dis. 2020 Nov-Dec; 38: 101906. https://doi.org/10.1016/j.tmaid.2020.101906. PMID: 33137493.

48. D'Souza R., Ashraf R., Rowe H., et al. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet Gynecol. 2021 Feb; 57(2): 195-203. https://doi.org/10.1002/uog.23116. PMID: 32959455.

49. PachecoL.D., SaadA.F., Saade G. Early acute respiratory support for pregnant patients with coronavirus disease 2019 (COVID-19) Infection. Obstet Gynecol. 2020 Jul; 136(1): 42-45. https://doi.org/10.1097/AOG.0000000000003929. PMID: 32349051.

50. SaadA.F., ChappellL., Saade G.R., Pacheco L.D. Corticosteroids in the management of pregnant patients with coronavirus disease (COVID-19). Obstet Gynecol. 2020 Oct; 136(4): 823-826. https://doi.org/10.1097/AOG.0000000000004103. PMID: 32769659.

51. Wang M., Lu S., Li S., Shen F. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer. Clin Chim Acta. 2013 Oct 21; 425: 176-180. https://doi.org/10.1016/j.cca.2013.08.006. PMID: 23954836.

52. Servante J., Swallow G., Thornton J.G., et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth. 2021 Feb 5; 21(1): 108. https://doi.org/10.1186/s12884-021-03568-0. PMID: 33546624.

53. Elbeddini A., Gerochi R., Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract. 2020 Oct 26; 13: 73. https://doi.org/10.1186/s40545-020-00274-8. PMID: 33117545.

54. Heit J.A., Kobbervig C.E., James A.H., et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005 Nov 15; 143(10): 697-706. https://doi.org/10.7326/0003-4819-143-10-200511150-00006. PMID: 16287790.

55. Reger B., Peterfalvi A., Litter I., et al. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women. Thromb Res. 2013 Apr; 131(4): e183-187. https://doi.org/10.1016/j.thromres.2013.02.005. PMID: 23481480.

56. Rentsch C.T., Beckman J.A., Tomlinson L., et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ. 2021 Feb 11; 372: n311. https://doi.org/10.1136/bmj.n311. PMID: 33574135.

57. Martinelli I., Ferrazzi E., Ciavarella A., et al. Pulmonary embolism in a young pregnant woman with COVID-19. Thromb Res. 2020 Jul; 191: 36-37. https://doi.org/10.1016/j.thromres.2020.04.022. PMID: 32371163.

58. Motta J.K., Ogunnaike R.O., Shah R., et al. Clinical outcomes with the use of prophylactic versus therapeutic anticoagulation in coronavirus disease 2019. Crit Care Explor. 2020 Dec 16; 2(12): e0309. https://doi.org/10.1097/CCE.0000000000000309. PMID: 33354679.

59. Tang N., Bai H., Chen X., et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 May; 18(5): 1094-1099. https://doi.org/10.1111/jth.14817. PMID: 32220112.

60. Brenner B. Enoxaparin use in pregnancy: state of the art. Womens Health (Lond). 2007 Jan; 3(1): 9-14. https://doi.org/10.2217/17455057.3.1.9. PMID: 19803860.

61. Frediansyah A., Nainu F., Dhama K., et al. Remdesivir and its antiviral activity against COVID-19: A systematic review. Clin Epidemiol Glob Health. 2021 Jan-Mar; 9: 123-127. https://doi.org/10.1016/j.cegh.2020.07.011. PMID: 32838064.

62. Tolcher M.C., McKinney J.R., Eppes C.S., et al. Prone positioning for pregnant women with hypoxemia due to coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020 Aug; 136(2): 259-261. https://doi.org/10.1097/AOG.0000000000004012. PMID: 32516274.

63. Lucarelli E., Behn C., Lashley S., et al. Mechanical ventilation in pregnancy due to COVID-19: A Cohort of Three Cases. Am J Perinatol. 2020 Aug; 37(10): 1066-1069. https://doi.org/10.1055/s-0040-1713664. PMID: 32544963.

64. Debrabandere M.L., Farabaugh D.C., Giordano C. A Review on mode of delivery during COVID-19 between december 2019 and April 2020. Am J Perinatol. 2021 Mar; 38(4): 332-341. https://doi.org/10.1055/s-0040-1721658. PMID: 33285608.

65. Lubbe W., Botha E., Niela-Vilen H., Reimers P. Breastfeeding during the COVID-19 pandemic - a literature review for clinical practice. Int Breastfeed J. 2020 Sep 14; 15(1): 82. https://doi.org/10.1186/s13006-020-00319-3. PMID: 32928250.